Echoplanar magnetic resonance imaging in acute stroke

Journal of Clinical Neuroscience

Volumn 7, Issue 1, 2000, Pages 3-8

  Davis, S ^a   Tress, B ^a   Barber, P A ^a   Darby, D ^a   Parsons, M ^a   Gerraty, R ^a   Yang, Q ^b   Li, T ^b   Donnan, G ^b   Desmond, P ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Diffusion; Echoplanar; Ischaemia; Magnetic resonance imaging; Perfusion; Stroke

Indexed keywords

CITICOLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMAGE ANALYSIS; NEUROPROTECTION; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; STROKE; TREATMENT OUTCOME;

EID: 0033932266     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.1999.0142     Document Type: Review

References (45)

1. Anderson CS, Jamrozick KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG. Ascertaining the true incidence of stroke: Experience from the Perth Community Stroke Study, 1989-1990. Med J Aust 1993;18:158:80-84.
2. Bennett SA, Magnus P. Trends in cardiovascular risk factors in Australia. Results from the National Heart Foundation's Risk Factor Prevalence Study, 1980-1989. Med J Aust 1994;161:519-527.
3. Davis SM. Tissue rescue therapy for ischaemic stroke. J Clin Neuroscience 1995;2:7-15.
4. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischaemia-the ischemic penumbra. Stroke 1981;12:723-725.
5. Ginsberg MD, Pulsinelli WA. The ischaemic penumbra, injury thresholds and the therapeutic window for acute stroke. Ann Neurol 1994;36:553-554.
6. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557-565.
7. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echoplanar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37:231-241.
8. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996; 16:53-59.
9. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM. Prediction of stroke outcome with echoplanar perfusion - and diffusion-weighted MRI. Neurology 1998;51:418-426.
10. Davis SM, Chua MG, Lichtenstein M, Rossiter SC, Binns D, Hopper JL. Cerebral hypoperfusion in stroke prognosis and brain recovery. Stroke 1993;24:1691-1696.
11. Baird AE, Donnan GA, Austin MC, Fitt GJ, Davis SM, McKay WJ. Reperfusion after thrombolytic therapy in ischemic stroke measured by singlephoton emission computed tomography. Stroke 1994;25:79-85.
12. Infeld B, Davis SM, Donnan GA, Lichtenstein M, Baird AE, Binns D, Mitchell PJ, Hopper JL. Streptokinase increases luxury perfusion after stroke. Stroke 1996;27:1524-1529.
13. Yasaka M, O'Keefe GJ, Chambers BR, Davis SM, Infeld B, O'Malley H, Baird AE, Hirano T, Donnan GA. Streptokinase in acute stroke: Effect on reperfusion and recanalization. Australian Streptokinase Trial Study Group. Neurology 1998;50:626-632.
14. Barber PA, Davis SM, Infeld B, Baird AE, Donnan GA, Jolley D, Lichtenstein M. Spontaneous reperfusion after ischemic stroke is associated with improved outcome. Stroke 1998;29:2522-2528.
15. Infeld B, Davis SM, Donnan GA, Yasaka M, Lichtenstein M, Mitchell PJ, Fitt GJ. Nimodipine and perfusion changes after stroke. Stroke (In Press).
16. Edelman RR, Wielopolski P, Schmitt F. Echoplanar MR imaging. Radiology 1994;192:600-612.
17. Sorenson G, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-Hellinger FR, Reese TG, Weisskoff RM, Davis TL, Suwanwela N, Can U, Moreira JA, Copen WA, Look RB, Finklestein SP, Rosen BR, Koroshetz WJ. Hyperacute Stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR Imaging. Radiology 1996;199:391-401.
18. Lutsep HL, Albers GW, DeCrespigny A, Kamat N, Marks MP, Moseley ME. Clinical utility of diffusion-weighted magnetic resonance Imaging in the assessment of ischemic stroke. Ann Neurol 1997;41:574-580.
19. Minematsu K, Li L, Sotak CH, Davis MA, Fisher M. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 1992;23:1304-1310.
20. Baird AE, Benfield A, Schlaug G, Siewart B, Lovblad KO, Edelman RR, Warach S. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;41:581-589.
21. Barber PA, Davis SM, Darby DG, Desmond PM, Gerraty RP, Yang Q, Jolley D, Donnan GA, Tress BM. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology 1999;52:1125-1132.
22. Warach S, Mosley M, Sorensen AG, Koroshetz W. Time course of diffusion imaging abnormalities in human stroke. Stroke 1996;27:1254-1255.
23. Warach S, Boska M, Welch KMA. Pitfalls and potential of clinical diffusionweighted MR imaging in acute stroke. Stroke 1997;28:481-482.
24. Lovblad, KO, Laubach HJ, Baird E, Curtin F, Schlaug G, Edelman RR, Warach S. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR 1998;19:1061-1066.
25. Kucharczyk J, Vexler ZS, Roberts TP, Asgari HS, Mintorovitch J, Derugin N, Watson AD, Moseley ME. Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia. Radiology 1993;188:711-717.
26. Edelman RR, Siewert B, Darby DG, Thangaraj V, Nobre AC, Mesulam MM, Warach S. Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency. Radiology 1994; 192:513-520.
27. Consolo HK, Davis SM, Barber PA, Darby DG, Desmond PM, Gerraty RP, Yang Q, Tress BM. Perfusion MRI versus HMPAO SPECT in stroke. Abstract. Cerebrovascular Diseases 1999;9:73.
28. Rordorf G, Koroshetz WJ, Copen WA, Cramer SC, Schaefer PW, Budzik RF Jr, Schwamm LH, Buonanno F, Sorensen AG, Gonzalez GI. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 1998;29:939-943.
29. Graham GD, Kalvach P, Blamire AM, Brass LM, Fayad PB, Pritchard JW. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke 1995;26:225-229.
30. Barker PB, Gillard JH, van Zijl PC, Soner BJ, Hanley DF, Agildere AM, Oppenheimer SM, Bryan RN. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994;192:723-732.
31. Powers, WJ, Zivin J. Magnetic resonance imaging in acute stroke: not ready for prime time. Neurology 1998;50:842-843.
32. Bryan RN. Diffusion-weighted imaging: to treat or not to treat? That is the question. Am J Neuroradiol 1998;19:396-397.
33. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998;18:583-609.
34. Barber PA, Davis SM, Darby DG, Desmond PM, Gerraty RP, Yang Q, Donnan GA, Tress BM. Screening for thrombolytic therapy in acute stroke: diffusionweighted imaging versus computed tomography. Abstract. Cerebrovascular Diseases 1999;9:73.
35. Patel R, Edelman R, Warach S. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke 1996;27:2321-2324.
36. Lovblad KO, Baird AE, Schlaug G, Benfield A, Siewert B, Voetsch B, Connor A, Burzynski C, Edelman RR, Warach S. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42:164-170.
37. Tong DC, Yenari MA, Alberts GW, O'Brien M, Marks MP, Mosley ME. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology 1998;50:864-870.
38. Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Tress BM, Davis SM. The topography of acute ischemic stroke using combined diffusionweighted and perfusion MRI. 1999 Submitted for publication.
39. Singer, MB, Chong J, Lu D, Schonewille WJ, Tuhrim S, Atlas SW. Diffusionweighted MRI in acute subcortical infarction. Stroke 1998;29:133-136.
40. Meadows ME, Fisher M, Minematsu K. Delayed treatment with a noncompetitive NMDA antagonist, CNS-1102, reduces infarct size in rats. Cerebrovasc Dis 1994;4:26-31.
41. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Sabounjian L. The effect of citicholine on lesion volume in acute stroke: a multicenter double blind placebo controlled trial. Stroke 1999;30:243(Abstract).
42. The National Institute of Neurological Disorders and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med 1995;333:1581-1587.
43. Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W. Guidelines for thrombolytic therapy for acute stroke: supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke 1996;27:1711-1718.
44. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study. JAMA 1995;274:1017-1025.
45. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Dies-Tejedor E, Trouillas P. Randomised, double-blind, placebo-controlled trial of thrombolytic therapy with intravenous alteplase in patients with acute ischaemic stroke. (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.